NEUP
Neuphoria·NASDAQ
--
--(--)
--
--(--)
NEUP fundamentals
During Q2 2026, Neuphoria (NEUP) reported revenue of --, a YoY change of 0.00%. Net income was 1.86M, a YoY change of 195.92%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | Q2,2026 | TTM |
|---|
Start Date | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | 662.72K -- | 15.00M -- | -13.27K -- | -- -- | -- -- | -- -- |
Sales and Services Revenue | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 662.72K -- | 15.00M -- | -13.27K -- | -- -- | 0 -100.00% | -- -- |
Operating Expenses | 5.47M -- | 4.55M -- | 2.39M -- | 5.48M -- | 3.57M -34.75% | 4.37M -4.10% | 3.02M +26.26% | 5.82M +6.28% | 5.65M +58.44% | 4.06M -6.99% | 18.56M -- |
Selling, General and Administrative Expenses | 2.38M -- | 2.52M -- | 1.20M -- | 2.38M -- | 1.67M -29.95% | 2.63M +4.42% | 1.41M +17.68% | 2.07M -13.06% | 1.87M +12.01% | 2.13M -19.10% | 7.47M -- |
General and Administrative Expenses | 2.38M -- | 2.52M -- | 1.20M -- | 2.38M -- | 1.67M -29.95% | 2.63M +4.42% | 1.41M +17.68% | 2.07M -13.06% | 1.87M +12.01% | 2.13M -19.10% | 7.47M -- |
Research and Development Expenses | 3.09M -- | 2.03M -- | 1.20M -- | 3.10M -- | 1.90M -38.45% | 1.74M -14.64% | 1.62M +34.83% | 3.75M +21.16% | 3.79M +99.15% | 697.72K -59.83% | 9.85M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.24M -- | -- -- |
Operating Income | -5.47M -- | -4.55M -- | -2.39M -- | -5.48M -- | -3.57M +34.75% | -3.70M +18.66% | 11.98M +600.29% | -5.84M -6.52% | -5.65M -58.44% | -4.06M -9.65% | -3.57M -- |
Non-Operating Income (Loss) | -39.75K -- | -36.36K -- | -367.73K -- | 2.76M -- | 2.63M +6717.58% | 1.77M +4973.39% | -796.22K -116.52% | -3.32M -220.26% | -4.29M -263.02% | 5.89M +232.44% | -2.51M -- |
Gain (Loss) on Change in Fair Value | -124.56K -- | 177.73K -- | -637.47K -- | 2.79M -- | 2.87M +2407.92% | 805.42K +353.18% | -976.68K -53.21% | -2.46M -188.25% | -4.37M -251.98% | 5.38M +567.91% | -2.43M -- |
Gain (Loss) on Foreign Currency Exchange | -1.64K -- | -363.51K -- | 216.85K -- | -61.55K -- | -280.04K -17027.65% | 629.50K +273.17% | 172.95K -20.25% | -937.41K -1423.10% | -61.73K +77.95% | -135.66K -121.55% | -961.85K -- |
Other Non-Operating Income (Loss) | -- -- | 94.71K -- | 271 -- | 234 -- | -- -- | 306.23K +223.34% | -5.23K -2028.78% | -1.10K -570.51% | -- -- | 478.96K +56.40% | -- -- |
Net Interest Expense | -86.44K -- | -54.72K -- | -52.62K -- | -26.33K -- | -36.10K +58.24% | -30.61K +44.05% | -12.74K +75.78% | -87.05K -230.63% | -142.00K -293.38% | -167.31K -446.50% | -409.09K -- |
Interest Income | -- -- | -- -- | -- -- | 220.10K -- | 36.10K -- | -- -- | -- -- | 166.50K -24.35% | 142.00K +293.38% | -- -- | -- -- |
Pretax Income From Continuing Operations | -5.51M -- | -4.59M -- | -2.76M -- | -2.72M -- | -936.97K +82.99% | -1.93M +57.91% | 11.18M +504.85% | -9.15M -236.27% | -9.94M -961.00% | 1.83M +194.70% | -6.08M -- |
Income Tax Expense | -34.79K -- | -34.79K -- | 16.38K -- | -34.12K -- | -132.19K -279.92% | 11.61K +133.36% | -81.19K -595.55% | -266.60K -681.46% | -34.79K +73.68% | -34.79K -399.72% | -417.38K -- |
Current Income Tax | -- -- | -- -- | -- -- | 51.85K -- | -- -- | -- -- | -- -- | 61 -99.88% | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -4.14M -- | -- -- | -- -- | -- -- | 279.59K +106.76% | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | 4.00M -- | -- -- | -- -- | -- -- | -748.02K -118.70% | -- -- | -- -- | -- -- |
Net Income | -5.47M -- | -4.55M -- | -2.78M -- | -2.69M -- | -804.79K +85.29% | -1.94M +57.33% | 11.26M +505.38% | -8.88M -230.61% | -9.91M -1130.95% | 1.86M +195.92% | -5.66M -- |
Net Income Attributable to Owners of the Company | -5.47M -- | -4.55M -- | -2.78M -- | -2.69M -- | -804.79K +85.29% | -1.94M +57.33% | 11.26M +505.38% | -8.88M -230.61% | -9.91M -1130.95% | 1.86M +195.92% | -5.66M -- |
Net Income Attributable to Common Stockholders | -5.47M -- | -4.55M -- | -2.78M -- | -2.69M -- | -804.79K +85.29% | -1.94M +57.33% | 11.26M +505.38% | -8.88M -230.61% | -9.91M -1130.95% | 1.86M +195.92% | -5.66M -- |
Other Comprehensive Income | -63.47K -- | 451.08K -- | -561.95K -- | 219.52K -- | 585.38K +1022.31% | -1.29M -385.63% | -195.82K +65.15% | 1.07M +386.24% | 49.22K -91.59% | 570.58K +144.28% | 1.49M -- |
Total Comprehensive Income | -5.54M -- | -4.10M -- | -3.34M -- | -2.47M -- | -219.41K +96.04% | -3.23M +21.24% | 11.07M +431.32% | -7.82M -216.77% | -9.86M -4392.71% | 2.43M +175.34% | -4.17M -- |
Total Comprehensive Income Attributable to Owners of the Company | -5.54M -- | -4.10M -- | -3.34M -- | -2.47M -- | -219.41K +96.04% | -3.23M +21.24% | 11.07M +431.32% | -7.82M -216.77% | -9.86M -4392.71% | 2.43M +175.34% | -4.17M -- |
Basic EPS | 0 -- | -5.31 -- | -2.83 -- | 0 -- | -0.62 -- | -1.23 +76.84% | 6.55 +331.45% | -4.49 -- | -4.41 -611.29% | 0.41 +133.33% | -1.94 -- |
Basic EPS from Continuing Operations | 0 -- | -5.31 -- | -2.83 -- | -- -- | -0.62 -- | -1.23 +76.84% | 6.55 +331.45% | -- -- | -4.41 -611.29% | 0.41 +133.33% | -- -- |
Diluted EPS | 0 -- | -5.31 -- | -2.83 -- | -- -- | -0.62 -- | -1.79 +66.29% | 6.55 +331.45% | -- -- | -4.41 -611.29% | -0.77 +56.98% | -- -- |
Diluted EPS from Continuing Operations | 0 -- | -5.31 -- | -2.83 -- | -- -- | -0.62 -- | -1.79 +66.29% | 6.55 +331.45% | -- -- | -4.41 -611.29% | -0.77 +56.98% | -- -- |
You can ask Aime
Did Neuphoria beat or miss consensus estimates last quarter?What guidance did Neuphoria's management provide for the next earnings period?What were the key takeaways from Neuphoria's earnings call?What were the key takeaways from Neuphoria’s earnings call?What factors drove the changes in Neuphoria's revenue and profit?What is Neuphoria's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Neuphoria year over year?What is the market's earnings forecast for Neuphoria next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
